Maki Tanaka

Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model

Y. Kodera, H. Kasuya, Y. Naoe, 2022, Scientific reports.

A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer

Y. Kodera, Y. Hirooka, H. Goto, 2018, BMC Cancer.

STING activator 2′3′‐cGAMP enhanced HSV‐1‐based oncolytic viral therapy

N. Mukoyama, M. Abdelmoneim, Shigeru Matsumura, 2024, Molecular oncology.